{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:34:48Z","timestamp":1760146488493,"version":"build-2065373602"},"reference-count":17,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Direct oral anticoagulants (DOACs) have become the cornerstone of stroke prevention in the management of atrial fibrillation (AF). While their efficacy in preventing catastrophic outcomes is well documented, the exploration of their effects on haematological parameters, particularly in clinically stable AF patients, remains markedly underrepresented in existing research. The aim of our investigation was to delineate the variations in key haematological parameters, with a special focus on haemoglobin (Hb), in a cohort of clinically stable patients afflicted with AF and receiving diverse oral anticoagulant treatments. Materials and Methods: In this retrospective study, 742 patients with AF were evaluated. Following exclusion criteria, 530 patients were included and categorised based on the change in their Hb levels (\u0394Hb &lt; 2 [n = 473] vs. \u0394Hb \u2265 2 [n = 57]) after one year of initial prescription of DOACs. Results: Patients in the \u0394Hb \u2265 2 g\/dL group demonstrated significantly higher baseline haemoglobin levels during the pre-DOAC period (13.5 [12.3\u201314.6] vs. 14.6 [13.1\u201315.7]; p = 0.002). Baseline haemoglobin was identified as a predictive factor for a decrease in Hb \u2265 2 g\/dL, with higher initial values being associated with more pronounced reductions (OR, 95% CI: 1.424 [1.178\u20131.723]; p &lt; 0.005). This pattern was observed consistently across various types and dosages of DOACs. Conclusions: This study underscores the importance of vigilant clinical monitoring for anaemia in patients undergoing DOAC therapy, even when their clinical course appears to be stable.<\/jats:p>","DOI":"10.3390\/medicina60111851","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T08:01:27Z","timestamp":1731312087000},"page":"1851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Direct Anticoagulant Therapy on Haematological Parameters in Atrial Fibrillation: Clinical Significance of Subclinical Haemoglobin Decrease"],"prefix":"10.3390","volume":"60","author":[{"given":"Metin","family":"\u00c7oksevim","sequence":"first","affiliation":[{"name":"Department of Cardiology, School of Medicine, Ondokuz May\u0131s University, 55200 Samsun, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130dris Bu\u011fra","family":"\u00c7erik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, School of Medicine, Ordu University, 52200 Ordu, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9951-2617","authenticated-orcid":false,"given":"\u00d6mer","family":"Kertmen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, School of Medicine, Amasya University, 05100 Amasya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ksel","family":"Da\u011fa\u015fan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alanya Training and Research Hospital, 07400 Antalya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-1397","authenticated-orcid":false,"given":"Murat","family":"Ero\u011flu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Evliya \u00c7elebi Training and Research Hospital, K\u00fctahya Health Sciences University, 43020 K\u00fctahya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufuk","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Cardiology, School of Medicine, Ondokuz May\u0131s University, 55200 Samsun, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"January","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1093\/eurheartj\/ehz155","article-title":"Oral anticoagulation among atrial fibrillation patients with anaemia: An observational cohort study","volume":"40","author":"Bonde","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_6","unstructured":"World Health Organization (1968). Nutritional Anaemias: Report of a WHO Scientific Group [Meeting Held in Geneva from 13 to 17 March 1967], World Health Organization."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijcard.2019.11.127","article-title":"Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: A subanalysis of the J-RHYTHM Registry","volume":"302","author":"Kodani","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.amjcard.2016.05.059","article-title":"Meta-analysis of the prognostic impact of anemia in patients undergoing percutaneous coronary intervention","volume":"118","author":"Kwok","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1253\/circj.CJ-17-0442","article-title":"Anemia Is Associated With Blunted Response to \u03b2-Blocker Therapy Using Carvedilol\u2014Insights From Japanese Chronic Heart Failure (J-CHF) Study","volume":"82","author":"Nagatomo","year":"2018","journal-title":"Circ. J."},{"key":"ref_10","first-page":"52","article-title":"Anemia in heart failure\u2014From guidelines to controversies and challenges","volume":"20","author":"Floria","year":"2018","journal-title":"Anatol. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ahj.2009.03.009","article-title":"Anemia: An independent predictor of death and hospitalizations among elderly patients with atrial fibrillation","volume":"157","author":"Sharma","year":"2009","journal-title":"Am. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/clc.23559","article-title":"Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL-AF registry","volume":"44","author":"Krittayaphong","year":"2021","journal-title":"Clin. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lavalle, C., Pierucci, N., Mariani, M.V., Piro, A., Borrelli, A., Grimaldi, M., Rossillo, A., Notarstefano, P., Compagnucci, P., and Perna, F. (Minerva Cardiol. Angiol., 2024). Italian Registry in the Setting of Atrial Fibrillation Ablation with Rivaroxaban-IRIS, Minerva Cardiol. Angiol., Online ahead of print.","DOI":"10.23736\/S2724-5683.24.06546-3"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/eurheartj\/ehz190","article-title":"Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: The ELIMINATE-AF trial","volume":"40","author":"Hohnloser","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1358863X11417622","article-title":"Factors related to a clinically silent peri-procedural drop in hemoglobin with coronary and peripheral vascular interventions","volume":"16","author":"Jaffery","year":"2011","journal-title":"Vasc. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.amjcard.2017.02.052","article-title":"Relation of baseline hemoglobin levels and adverse events in patients with acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy and harmonizing outcomes with revascularization and stents in acute myocardial infarction trials)","volume":"119","author":"Brener","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sairaku, A., Morishima, N., Kinoshita, H., Amioka, M., Maeda, J., Watanabe, Y., and Nakano, Y. (2020). A smaller post-procedural hemoglobin fall in patients with preexisting anemia undergoing atrial fibrillation ablation with a single skipped dose of direct oral anticoagulants: Another anemia paradox. Authorea Prepr.","DOI":"10.22541\/au.159586008.85849592"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:29:56Z","timestamp":1760113796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["medicina60111851"],"URL":"https:\/\/doi.org\/10.3390\/medicina60111851","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2024,11,11]]}}}